Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Arvinas is a leading US-based biotechnology company specializing in the degradation of disease-causing proteins. Through its innovative PROTAC® technology, the company develops novel targeted cancer therapies and treatments for diseases that have previously been considered difficult to address.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Arvinas is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Arvinas last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at 2.58 USD.
Arvinas has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.